NCT01615731View on ClinicalTrials.gov

Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

July 31, 2013

Conditions
Abortion, Induced
Interventions
DRUG

Mifepristone

200mg Mifepristone orally

OTHER

Hygroscopic cervical dilators

Dilapan-S osmostic cervical dilators inserted through the internal os

DRUG

Misoprostol

400mcg buccal misoprostol 90 minutes pre-op

DRUG

Intra-amniotic digoxin

1mg digoxin administered intra-amniotically \~24 hours pre-op

Trial Locations (2)

94305

Stanford University Medical Center, Stanford

95128

Santa Clara Valley Medical Center, San Jose

All Listed Sponsors
collaborator

Santa Clara Valley Medical Center

OTHER

lead

Stanford University

OTHER

NCT01615731 - Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks | Biotech Hunter | Biotech Hunter